Skip to main content
logo
Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.600
-0.020 (-0.55%)
Oct 9, 2026, 4:08 PM HKT

HKG:2591 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23
Market Capitalization
1,64513,997--
Market Cap Growth
-90.89%---
Enterprise Value
63813,255--
Last Close Price
3.6030.64--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23
PS Ratio
9.2995.64--
PB Ratio
1.5111.94--
P/TBV Ratio
1.5412.19--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23
EV/Sales Ratio
3.6190.57--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.160.160.010.07
Net Debt / Equity Ratio
-0.92-0.99-0.99-0.92
Net Debt / EBITDA Ratio
2.623.064.500.88
Net Debt / FCF Ratio
2.403.294.723.67
Asset Turnover
0.140.11--
Inventory Turnover
0.400.20--
Quick Ratio
3.142.675.821.94
Current Ratio
3.502.936.072.66
Return on Equity (ROE)
-41.16%-36.91%-23.27%-
Return on Assets (ROA)
-19.04%-17.30%-11.61%-
Return on Capital Employed (ROCE)
-35.70%-32.50%-23.80%-100.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23
Earnings Yield
-23.47%-2.71%--
FCF Yield
-25.44%-2.51%--
Buyback Yield / Dilution
-7.64%-3.44%-9.63%-